Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bianca Raffaelli

Showing results (21-30 of 91) with videos related to

Pageof 10
Sort By:
Journal of Clinical Medicine|September 9, 2023
Changes in Health-Related Quality of Life in Patients with Therapy-Resistant Migraine during Treatment with Erenumab in an Ambulatory Care SettingHannah Haneke, Schirin Sulaiman, Sina Nickel, et al.
MMW Fortschritte Der Medizin|May 5, 2021
Bianca Raffaelli, Carl Göbel, Lars Neeb, et al.
Cephalalgia : an International Journal of Headache|June 8, 2024
Induction of cGMP-mediated migraine attacks is independent of CGRP receptor activationBianca Raffaelli, Thien Phu Do, Håkan Ashina, et al.
Neurology and Therapy|March 14, 2025
Menopause, Perimenopause, and Migraine: Understanding the Intersections and Implications for TreatmentMarta Waliszewska-Prosół, Giovanni Grandi, Raffaele Ornello, et al.
Cephalalgia : an International Journal of Headache|September 28, 2021
Migraine evolution after the cessation of CGRP(-receptor) antibody prophylaxis: a prospective, longitudinal cohort studyBianca Raffaelli, Maria Terhart, Lucas Hendrik Overeem, et al.
Journal of Neurology|June 28, 2018
Brain imaging in pregnant women with acute headacheBianca Raffaelli, Lars Neeb, Heike Israel-Willner, et al.
The Journal of Headache and Pain|September 20, 2023
Menstrual migraine is caused by estrogen withdrawal: revisiting the evidenceBianca Raffaelli, Thien Phu Do, Basit Ali Chaudhry, et al.
Internal and Emergency Medicine|May 27, 2026
CGRP-targeted therapies for migraine and the risk of infectionClaudio Tana, Bianca Raffaelli, Roberta Messina, et al.
Frontiers in Neurology|June 18, 2020
Erenumab in Chronic Migraine Patients Who Previously Failed Five First-Line Oral Prophylactics and OnabotulinumtoxinA: A Dual-Center Retrospective Observational StudyBianca Raffaelli, Rea Kalantzis, Jasper Mecklenburg, et al.
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
A Scoping Review and Meta-Analysis of Anti-CGRP Monoclonal Antibodies: Predicting ResponseJa Bin Hong, Kristin Sophie Lange, Lucas Hendrik Overeem, et al.
Pageof 10

Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
Journal of Clinical Medicine|September 9, 2023
Changes in Health-Related Quality of Life in Patients with Therapy-Resistant Migraine during Treatment with Erenumab in an Ambulatory Care SettingHannah Haneke, Schirin Sulaiman, Sina Nickel, et al.
MMW Fortschritte Der Medizin|May 5, 2021
Bianca Raffaelli, Carl Göbel, Lars Neeb, et al.
Cephalalgia : an International Journal of Headache|June 8, 2024
Induction of cGMP-mediated migraine attacks is independent of CGRP receptor activationBianca Raffaelli, Thien Phu Do, Håkan Ashina, et al.
Neurology and Therapy|March 14, 2025
Menopause, Perimenopause, and Migraine: Understanding the Intersections and Implications for TreatmentMarta Waliszewska-Prosół, Giovanni Grandi, Raffaele Ornello, et al.
Cephalalgia : an International Journal of Headache|September 28, 2021
Migraine evolution after the cessation of CGRP(-receptor) antibody prophylaxis: a prospective, longitudinal cohort studyBianca Raffaelli, Maria Terhart, Lucas Hendrik Overeem, et al.
Journal of Neurology|June 28, 2018
Brain imaging in pregnant women with acute headacheBianca Raffaelli, Lars Neeb, Heike Israel-Willner, et al.
The Journal of Headache and Pain|September 20, 2023
Menstrual migraine is caused by estrogen withdrawal: revisiting the evidenceBianca Raffaelli, Thien Phu Do, Basit Ali Chaudhry, et al.
Internal and Emergency Medicine|May 27, 2026
CGRP-targeted therapies for migraine and the risk of infectionClaudio Tana, Bianca Raffaelli, Roberta Messina, et al.
Frontiers in Neurology|June 18, 2020
Erenumab in Chronic Migraine Patients Who Previously Failed Five First-Line Oral Prophylactics and OnabotulinumtoxinA: A Dual-Center Retrospective Observational StudyBianca Raffaelli, Rea Kalantzis, Jasper Mecklenburg, et al.
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
A Scoping Review and Meta-Analysis of Anti-CGRP Monoclonal Antibodies: Predicting ResponseJa Bin Hong, Kristin Sophie Lange, Lucas Hendrik Overeem, et al.
Pageof 10